Development and Pilot Application of a Solution-Focused Intervention for Social Isolation in Elderly Diabetic Foot Patients
Construction and Preliminary Application of a Solution-Focused Model-Based Intervention Program for Social Isolation in Elderly Patients With Diabetic Foot Ulcers
The goal of this interventional study is to develop and preliminarily evaluate a solution-focused model-based intervention program for reducing social isolation in elderly patients with diabetic foot ulcers. It will also learn about the feasibility and safety of the intervention program. The main questions it aims to answer are:
Does the solution-focused intervention program effectively reduce social isolation levels in elderly patients with diabetic foot ulcers?
What effects does the intervention have on patients' foot self-care behaviors, social participation, social support, depressive symptoms, and glycemic control?
Researchers will compare an intervention group (receiving the solution-focused intervention combined with routine nursing care) to a control group (receiving routine nursing care only) to see if the intervention program works to alleviate social isolation in this population.
Participants will:
Complete a set of validated questionnaires (including assessments of social isolation, foot self-care behaviors, social support, social participation, and depressive symptoms) and undergo fasting blood glucose measurement at four time points: baseline, after 3 intervention sessions, at intervention completion, and 1-month post-intervention
Attend 5 weekly sessions (0.5 -1 hours each) of the solution-focused intervention program, which follows five core steps: problem description, goal setting, exception exploration, feedback, and progress evaluation (intervention group only)
Receive routine nursing care including blood glucose monitoring, dietary management, medication guidance, psychological support, and activity instructions (both groups)
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Junnan Song
- Número de telefone: +86 18712096043
- E-mail: junnansong00@163.com
Locais de estudo
-
-
Anhui
-
Hefei, Anhui, China, 230031
- The First Affiliated Hospital of Anhui Medical University
-
Contato:
- Junnan Song
- Número de telefone: +86 18712096043
- E-mail: junnansong00@163.com
-
Contato:
- E-mail: junnansong00@163.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
(1) Meet the current Chinese criteria for older adults, aged ≥60 years;
(2) Clinically diagnosed with diabetic foot (DF);
(3) Voluntarily agree to participate in this study after being informed of the study purpose by the researcher.
Exclusion Criteria:
(1) Severe cognitive impairment or mental disorders: patients definitively diagnosed with Parkinson's disease, senile dementia, or severe depression by a Class II-A or higher hospital; or those with a score below 9 on the Mini-Mental State Examination (MMSE) indicating severe cognitive impairment;
(2) Severe communication impairment: patients unable to communicate normally with others due to hearing impairment, speech impairment, or other related conditions;
(3) Patients unable to complete the questionnaire survey for any reason;
(4) Patients currently participating in other trials that may affect the results of this study.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Triplo
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Grupo de controle
|
|
|
Outro: Grupo de intervenção
|
Researchers will compare an intervention group (receiving the solution-focused intervention plus routine care) to a control group (receiving routine care only). Participants will complete validated questionnaires (LSNS-6, NAFF, SSRS, IPA, CES-D-10) and undergo fasting blood glucose measurement at four time points: baseline, after 3 sessions, at intervention completion, and 1-month post-intervention. The intervention group will attend 5 weekly sessions (1-1.5 hours each) following five core steps: problem description, goal setting, exception exploration, feedback, and progress evaluation. Both groups receive routine care including blood glucose monitoring, dietary management, medication guidance, psychological support, and activity instructions. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Level of Social Isolation
Prazo: From enrollment to the end of treatment at 5 weeks
|
Measured by the Lubben Social Network Scale-6 (LSNS-6) , an abbreviated version of the original Lubben Social Network Scale developed by Lubben et al.
The LSNS-6 assesses social network status from two dimensions: family network (3 items) and friend network (3 items), totaling 6 items.
Each item is rated on a 6-point Likert scale (0 = none, 1 = one, 2 = two, 3 = three to four, 4 = five to eight, 5 = nine or more).
Total scores range from 0 to 30.
A total score <12 indicates social isolation.
Family network score <6 indicates family network isolation, and friend network score <6 indicates friend network isolation.
The Chinese version has demonstrated adequate internal consistency with a Cronbach's α of 0.832.
|
From enrollment to the end of treatment at 5 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Social support level
Prazo: From enrollment to the end of treatment at 5 weeks.
|
Social support level measured by the Medical Outcomes Study Social Support Survey (MOS-SSS).
The MOS-SSS contains 19 items across four dimensions: emotional/informational support (8 items), tangible support (4 items), affectionate support (3 items), and positive social interaction (4 items).
Each item is rated on a 5-point Likert scale (1=none of the time, 5=all of the time).
Total scores are transformed to a 0-100 scale, with higher scores indicating better social support.
The Chinese version has demonstrated good reliability and validity, with a Cronbach's α of 0.91.
|
From enrollment to the end of treatment at 5 weeks.
|
|
Social participation level
Prazo: From enrollment to the end of treatment at 5 weeks.
|
Social participation level measured by the Social Participation Scale.
This scale assesses the frequency and diversity of social activities across multiple domains, including family interactions, community activities, and social gatherings.
Each item is rated on a 5-point Likert scale (1=never, 5=very often).
Higher total scores indicate a higher level of social participation.
The scale has been validated in older adult populations with chronic diseases, demonstrating satisfactory psychometric properties with a Cronbach's α of 0.85.
|
From enrollment to the end of treatment at 5 weeks.
|
|
Depressive symptoms
Prazo: From enrollment to the end of treatment at 5 weeks.
|
Depressive symptoms measured by the Patient Health Questionnaire-9 (PHQ-9).
The PHQ-9 consists of 9 items corresponding to the DSM-IV diagnostic criteria for major depressive disorder.
Each item is rated on a 4-point Likert scale (0=not at all, 1=several days, 2=more than half the days, 3=nearly every day) based on symptom frequency over the past two weeks.
Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms (0-5 minimal, 6-10 mild, 11-15 moderate, 16-20 moderately severe, 21-27 severe).
Cronbach's α=0.89.
|
From enrollment to the end of treatment at 5 weeks.
|
|
Glycemic control (fasting blood glucose)
Prazo: From enrollment to the end of treatment at 5 weeks.
|
Glycemic control measured by fasting blood glucose (FBG) in millimoles per liter (mmol/L).
Venous blood samples are collected after an 8-hour overnight fast and analyzed using the standardized glucose oxidase method.
Lower FBG values indicate better glycemic control.
According to the Chinese Diabetes Society guidelines, normal FBG is 3.9-6.1 mmol/L.
This objective biomarker provides a reliable assessment of short-term glycemic status.
|
From enrollment to the end of treatment at 5 weeks.
|
|
Diabetic foot self-care behaviors
Prazo: From enrollment to the end of treatment at 5 weeks.
|
Diabetic foot self-care behaviors measured by the Diabetic Foot Self-Care Behavior Scale.
This scale evaluates patients' adherence to recommended foot care practices, including daily foot inspection, proper washing and drying, moisturizing, nail care, appropriate footwear selection, and avoiding barefoot walking.
Items are rated on a 5-point Likert scale (1=never, 5=always).
Higher total scores indicate better adherence to diabetic foot self-care behaviors.
The scale has shown good reliability with a Cronbach's α of 0.88.
|
From enrollment to the end of treatment at 5 weeks.
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- 81250948
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .